PCMA Unveils New Campaign on the Value of Pharmacy Benefit Managers
February 04, 2019
As the debate on high-cost prescription drugs continues and policymakers seek solutions to reduce out-of-control prices for consumers, the Pharmaceutical Care...
Filter by:
Choose a Topic
Filter by Year:Clear Filters- Press Releases
- Biosimilars
- Drug Abuse Prevention
- Drug Adherence Programs
- Drug Cost Management
- Drug Coupons & Assistance Programs
- Drug Coverage Mandates
- Drug Price Negotiations & Rebates
- Employers, Unions, & Insurers
- FEHBP Program
- Formulary Design
- Fraud, Waste, & Abuse
- Generic Drug Utilization
- Health Insurance Marketplace (ACA)
- Home Delivery of Drugs
- Mark Merritt
- Medicaid
- Medicare Part D
- Patient Cost Sharing
- Pharmacy Networks
- Pharmacy Reimbursement & Contracting
- REMS Management
- Specialty Benefit Design
- Specialty Pharmacies
- Specialty Pharmacy Networks
- TRICARE
- Value & Outcomes-Based Contracting
PCMA Statement on the Administration’s Prescription Drug Rebate Proposed Rule
January 31, 2019
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Health and...
PCMA Offers Policy Solutions to Reduce Prescription Drug Costs
January 28, 2019
(Washington, D.C.) — As Congress begins to examine high prescription drug prices, the Pharmaceutical Care Management Association (PCMA) sent letters...
PCMA Welcomes New Appointments, Announces New Roles
January 02, 2019
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing the additions of Amanda Frost as Assistant Vice...
PCMA: Drug Manufacturer Price Hikes Offset by Rebates
December 20, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on reports that...
PCMA: Setting the Record Straight on the Pennsylvania Auditor General’s Medicaid Report
December 11, 2018
(Washington, D.C.) — The Pennsylvania Auditor General’s report on Medicaid and pharmacy benefit managers (PBMs) is undermined by failing to...
PCMA Statement on National Healthcare Expenditure Data Showing Lower Health Spending
December 07, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on new National Health...
PCMA Statement on the Administration’s Proposed Medicare Part D Rule
November 26, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement in response to the Administration’s...
PCMA Statement on the Administration’s Proposed Medicare Part B Pricing Model
October 25, 2018
Pharmaceutical Care Management Association President and CEO JC Scott issued the following statement on the Administration’s proposed Medicare Part B pricing model:...
PCMA Applauds the Administration for Enacting Legislation to Curb America’s Opioid Crisis
October 24, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) recognizes today’s enactment of historic legislation, the SUPPORT for Patients and Communities Act (H.R....
PCMA Statement on the Administration’s Proposal Requiring List Prices of Drugs in TV Ads
October 15, 2018
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott released the following statement on the Department...
October 10, 2018
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) released the following statement on President Trump signing into law S. 2553/...